Andon Health Stock Hits Day Low of CNY 67.07 Amid Price Pressure

Andon Health Co., a large-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 3.83% on June 8, 2026. The stock reached an intraday low of CNY 67.07, reflecting a challenging market environment. Over the past week, Andon Health has seen a significant decrease of 12.62%, while its performance over the last month shows a decline of 10.72%. In contrast, the China Shanghai Composite index has also faced downward pressure, but to a lesser extent, with a 2.43% drop over the same week and a 5.28% decline over the month. Despite a strong year-to-date performance of 69.76% and a remarkable 749.62% increase over the past five years, recent financial metrics indicate underlying difficulties. The company reported a net sales decrease of 11.69% and a substantial drop in net profit of 46.47%. Additionally, the debt-equity ratio stands at -0.09, highlighting financial leverage concerns. As Andon Health navigates these challenges, its stock performance remains closely monitored within the broader market context.